Quantitative description of nuclear morphology in assessing resistance of sarcoma 180 to adriamycin.
Resistance to adriamycin generally is explained through changes of cell/drug interactions that possibly reflect structural alterations of intracellular targets. One of the main targets of adriamycin is believed to be nuclear chromatin. In order to recognize chromatin alterations, we studied cell nuclei morphology and chromatin structure by means of digital image analysis. The studies were performed in both adriamycin-sensitive and -resistant Sarcoma 180 cell lines which were cultured under growth-stimulated and nonstimulated conditions. Using specially developed methods, we extracted parameters characterizing geometrical, optical, and structural properties of the cell nuclei from light microscopical images. The latter parameters concerned microscopical appearances of condensed chromatin and were described by features of high-optical-density regions. The results demonstrated that the quantitative criteria applied enabled the discrimination of sensitive and resistant cells. The most important parameters are the nuclear size, number, distribution, and optical density of condensed chromatin regions. In addition, the criteria permit recognition of changes related to differences in the growth conditions of the cells. The data of the image analysis suggest that adriamycin resistance in Sarcoma 180 cells is associated with characteristic patterns of cell nuclear morphology which can be described with a sufficient number of appropriate parameters. The advantages of image analysis are evident when these results are compared with the flow cytometric findings. The conclusion is that structural features of nuclear chromatin provide information essential for the assessment of drug resistance.
Institute for Experimental Pathology, German Cancer Research Center, Heidelberg.
D
D
Komitowski
J
J
Sonka
B
B
Schmitt
S
S
Muto
D000818:Animals; D002460:Cell Line; D002467:Cell Nucleus / Q000473:pathology*; D002843:Chromatin / Q000648:ultrastructure; D004317:Doxorubicin / Q000494:pharmacology*; D004351:Drug Resistance; D005434:Flow Cytometry; D007091:Image Processing, Computer-Assisted; D051379:Mice; D012510:Sarcoma 180 / Q000188:drug therapy / Q000648:ultrastructure*
D002843:Chromatin; D004317:Doxorubicin